Minerva Neurosciences NERV
NASDAQ NERV
$4.43 -0.26 (-5.54%)
At close: Sep 4, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Change in Acquisitions & Divestments (2015 - 2020)

Minerva Neurosciences' (NERV) quarterly Change in Acquisitions & Divestments came in at $3.0 million in Q3 2020, down 91.63% YoY from $35.8 million in Q4 2019, and down 33.33% on a QoQ basis from $4.5 million in Q2 2020.

Analysis

Minerva Neurosciences (NERV) Change in Acquisitions & Divestments (2015 - 2020) Analysis & Trends

Minerva Neurosciences (NERV) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $3.0 million in Q3 2020.

  • Quarterly Change in Acquisitions & Divestments fell 91.63% year-over-year to $3.0 million in Q3 2020, while the trailing twelve-month figure through Dec 2020 was $28.4 million (down 62.22% YoY) and the FY2020 annual result came in at $28.4 million, down 62.22% from the prior year.
  • Change in Acquisitions & Divestments declined to $3.0 million in Q3 2020, from $4.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $39.2 million in Q1 2018 to a low of $1.4 million in Q2 2016.
  • A 4-year average of $16.5 million and a median of $9.2 million in 2019 frame the typical range for Change in Acquisitions & Divestments.
  • The widest YoY moves for Change in Acquisitions & Divestments: up 132.22% in 2020, down 91.63% in 2020.
  • Tracing NERV's Change in Acquisitions & Divestments over 4 years: stood at $8.4 million in 2016, then sank by 36.72% to $5.3 million in 2018, then soared by 76.11% to $9.3 million in 2019, then sank by 67.86% to $3.0 million in 2020.
  • The last three Change in Acquisitions & Divestments figures came in at $3.0 million (Q3 2020), $4.5 million (Q2 2020), and $20.9 million (Q1 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Minerva Neurosciences 207.37 Mn 207.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 3.00 Mn
Jun 30, 2020 4.50 Mn
Mar 31, 2020 20.90 Mn
Dec 31, 2019 9.33 Mn
Sep 30, 2019 35.85 Mn
Jun 30, 2019 21.00 Mn
Mar 31, 2019 9.00 Mn
Dec 31, 2018 5.30 Mn
Sep 30, 2018 29.50 Mn
Jun 30, 2018 36.10 Mn
Mar 31, 2018 39.25 Mn
Sep 30, 2016 8.38 Mn
Jun 30, 2016 1.40 Mn
Mar 31, 2016 8.04 Mn
Dec 31, 2015 4.05 Mn